A Novel Type of Dendritic Cell in Prevention of Glomerulonephritis
预防肾小球肾炎的新型树突状细胞
基本信息
- 批准号:8598160
- 负责人:
- 金额:$ 1.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-04-07 至 2016-03-31
- 项目状态:已结题
- 来源:
- 关键词:Antigen PresentationApoptosisAutoimmune ProcessAutoimmunityBiochemicalBiological AssayCD8B1 geneCell Adhesion Molecule GeneCell Adhesion MoleculesCellsDataDefectDendritic CellsDevelopmentDiseaseFailureFibrosisGene ExpressionGlomerular basement membrane antibodyGlomerulonephritisGrantHumanImmune ToleranceImmunotherapyIn VitroInbred WKY RatsInduction of ApoptosisInfiltrationInflammationLeadLeukocyte TraffickingLeukocytesLigandsLiposomesMediatingModelingMolecularOrganPathogenesisPolysialic AcidPopulationPopulation SizesPreventionProteinsRat StrainsRattusReceptor CellRecoveryRecruitment ActivitySpecificityStagingT-LymphocyteTestingTimeTumor Necrosis Factor Ligand Superfamily Member 6Workbasechemokinechemokine receptorexpression vectorgenetic manipulationin vivomodel developmentnovelnovel therapeuticsreceptortrafficking
项目摘要
DESCRIPTION (provided by applicant): Autoimmune anti-GBM glomerulonephritis (GN) is currently incurable. We aim to elucidate pathogenesis of this disease, which may lead to development of a novel therapeutic strategy. In our rat model for anti-GBM GN, LEW rats spontaneously recover from early inflammation. Observations on this naturally occurring recovery mechanism had led to our working hypothesis for the current grant: A novel glomeruli- infiltrating CD8 + DC (GIL CD8 + DC) terminated autoimmune damage in glomeruli by inducing apoptosis in self-reactive T cells through antigen presentation; failure in this mechanism led to uncontrolled glomerular damage as seen in GN-susceptible WKY rats. In the past 3 years, we have verified our hypothesis. First, we demonstrated that GIL CD8 + DC induced apoptosis in T cells by its intracellular Fas-L. Second, timely infiltration of GIL CD8 + DC into glomeruli was decisive for the recovery. Third, we delineated the lineage of GIL CD8 + DCs and identified its precursor in PBL. Most importantly, transfer of PBL precursor of GIL CD8 + DCs of LEW rats cured GN in GN-susceptible WKY rats. Thus, defects in GIL CD8 + DCs are responsible for GN in WKY rats. In addition, our preliminary data suggested that defect in expression of several leukocyte- trafficking related molecules in precursor of GIL CD8 + DCs in WKY rats may be responsible for the delay. Thus, mimicking this natural recovery mechanism in rats may lead to a potential immunotherapy for human autoimmune GN. We hypothesize that timely expression of leukocyte trafficking related molecules in both GIL CD8 + DC and inflamed glomeruli governs timely infiltration. This renewal application will investigate how the CD8 + DCs timely infiltrate glomeruli with emphasis on leukocyte trafficking related molecules in both PBL CD8 + precursor and inflamed glomeruli in Aims 1 and 3. We will further test if enhancing the cell's ability in timely infiltration through genetic manipulation will cure GN in GN-susceptible WKY rats (Aim 2). Accomplishment of those aims will not only reveal a unique immune tolerance mechanism occurring in the target organ, but also provide a working model for development of cell-based immunotherapy for autoimmune GN.
描述(由申请方提供):自身免疫性抗GBM肾小球肾炎(GN)目前无法治愈。我们的目的是阐明这种疾病的发病机制,这可能会导致一种新的治疗策略的发展。在我们的抗GBM GN大鼠模型中,LEW大鼠自发地从早期炎症中恢复。对这种自然发生的恢复机制的观察导致了我们对当前资助的工作假设:一种新的肾小球浸润性CD 8 + DC(GIL CD 8 + DC)通过抗原呈递诱导自身反应性T细胞凋亡来终止肾小球中的自身免疫损伤;这种机制的失败导致了不受控制的肾小球损伤,如在GN敏感的WKY大鼠中所见。在过去的三年里,我们已经验证了我们的假设。首先,我们证明GIL CD 8 + DC通过其细胞内的Fas-L诱导T细胞凋亡。第二,GIL CD 8 + DC及时浸润到肾小球是恢复的决定性因素。第三,我们描述了GIL CD 8 + DC的谱系,并在PBL中鉴定了其前体。最重要的是,移植LEW大鼠GIL CD 8 + DCs的PBL前体治疗GN敏感WKY大鼠的GN。因此,GIL CD 8 + DC的缺陷是WKY大鼠GN的原因。此外,我们的初步数据表明,WKY大鼠GIL CD 8 + DC前体中几种白细胞运输相关分子的表达缺陷可能是导致延迟的原因。因此,在大鼠中模仿这种自然恢复机制可能会导致人类自身免疫性GN的潜在免疫疗法。我们推测,及时表达白细胞运输相关分子在GIL CD 8 + DC和炎症肾小球及时浸润。本更新申请将研究CD 8 + DC如何及时浸润肾小球,重点是PBL CD 8+前体和炎症肾小球中的白细胞运输相关分子,目的1和3。我们将进一步测试通过遗传操作增强细胞及时渗透的能力是否会治愈GN敏感WKY大鼠中的GN(目的2)。这些目标的实现不仅将揭示靶器官中发生的独特免疫耐受机制,而且还将为开发基于细胞的自身免疫性GN免疫治疗提供工作模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YAHUAN LOU其他文献
YAHUAN LOU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YAHUAN LOU', 18)}}的其他基金
A Novel Type of Dendritic Cell in Prevention of Glomerulonephritis
预防肾小球肾炎的新型树突状细胞
- 批准号:
8449742 - 财政年份:2008
- 资助金额:
$ 1.42万 - 项目类别:
A Novel Type of Dendritic Cell in Prevention of Glomerulonephritis
预防肾小球肾炎的新型树突状细胞
- 批准号:
7602997 - 财政年份:2008
- 资助金额:
$ 1.42万 - 项目类别:
A Novel Type of Dendritic Cell in Prevention of Glomerulonephritis
预防肾小球肾炎的新型树突状细胞
- 批准号:
8295656 - 财政年份:2008
- 资助金额:
$ 1.42万 - 项目类别:
A Novel Type of Dendritic Cell in Prevention of Glomerulonephritis
预防肾小球肾炎的新型树突状细胞
- 批准号:
8638947 - 财政年份:2008
- 资助金额:
$ 1.42万 - 项目类别:
Role of T Cells in Mediating Glomerulonephritis
T 细胞在介导肾小球肾炎中的作用
- 批准号:
6545628 - 财政年份:2002
- 资助金额:
$ 1.42万 - 项目类别:
相似国自然基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
- 批准号:LBY21H010001
- 批准年份:2020
- 资助金额:0.0 万元
- 项目类别:省市级项目
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
- 批准号:81703335
- 批准年份:2017
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
- 批准号:81670594
- 批准年份:2016
- 资助金额:58.0 万元
- 项目类别:面上项目
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
- 批准号:81470791
- 批准年份:2014
- 资助金额:73.0 万元
- 项目类别:面上项目
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
- 批准号:81301123
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
- 批准号:81101529
- 批准年份:2011
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
- 批准号:39500043
- 批准年份:1995
- 资助金额:9.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 1.42万 - 项目类别:
Development of an apoptosis biosensor for monitoring of breast cancer
开发用于监测乳腺癌的细胞凋亡生物传感器
- 批准号:
10719415 - 财政年份:2023
- 资助金额:
$ 1.42万 - 项目类别:
Interrogating the Fgl2-FcγRIIB axis on CD8+ T cells: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
询问 CD8 T 细胞上的 Fgl2-FcγRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10605856 - 财政年份:2023
- 资助金额:
$ 1.42万 - 项目类别:
Novel targeted therapy for FGFR inhibitor-resistant urothelial cancer and apoptosis based therapy for urothelial cancer
FGFR抑制剂耐药性尿路上皮癌的新型靶向治疗和基于细胞凋亡的尿路上皮癌治疗
- 批准号:
23K08773 - 财政年份:2023
- 资助金额:
$ 1.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mechanistic analysis of apoptosis induction by HDAC inhibitors in head and neck cancer
HDAC抑制剂诱导头颈癌凋亡的机制分析
- 批准号:
23K15866 - 财政年份:2023
- 资助金额:
$ 1.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Interrogating the Fgl2-FcgRIIB axis: A novel mechanism mediating apoptosis of tumor-specific memory CD8+ T cells
探究 Fgl2-FcgRIIB 轴:介导肿瘤特异性记忆 CD8 T 细胞凋亡的新机制
- 批准号:
10743485 - 财政年份:2023
- 资助金额:
$ 1.42万 - 项目类别:
Investigating the role of apoptosis-resistance and the tumor environment on development and maintenance of sacrococcygeal teratomas
研究细胞凋亡抗性和肿瘤环境对骶尾部畸胎瘤发生和维持的作用
- 批准号:
10749797 - 财政年份:2023
- 资助金额:
$ 1.42万 - 项目类别:
The effects of glucose on immune cell apoptosis and mitochondrial membrane potential and the analysis of its mechanism by which glucose might modulate the immune functions.
葡萄糖对免疫细胞凋亡和线粒体膜电位的影响及其调节免疫功能的机制分析。
- 批准号:
22K09076 - 财政年份:2022
- 资助金额:
$ 1.42万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
XAF1 IN P53 SIGNALING, APOPTOSIS AND TUMOR SUPPRESSION
P53 信号传导、细胞凋亡和肿瘤抑制中的 XAF1
- 批准号:
10583516 - 财政年份:2022
- 资助金额:
$ 1.42万 - 项目类别:
Role of Thioredoxin system in regulation of autophagy-apoptosis cross talk in neurons: Uncovering Novel Molecular Interactions.
硫氧还蛋白系统在神经元自噬-凋亡串扰调节中的作用:揭示新的分子相互作用。
- 批准号:
RGPIN-2019-05371 - 财政年份:2022
- 资助金额:
$ 1.42万 - 项目类别:
Discovery Grants Program - Individual